ChugaiCHUGAI PHARMACEUTICAL CO., LTD.4519東証プライム医薬品FY ending Dec 2023, consolidated, IFRS

Chugai FY ending Dec 2021 results

Chugai brought in ¥999.8B in revenue.

Out of every ¥100 of sales, about ¥42 is left as operating profit.

Revenue changed +27.0% from the prior year, operating profit +40.1%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +27.0% · profit +40.1%, calculated from disclosed figures.

Operating leverage: 1.48× (profit growth ÷ revenue growth)

What changed from last year

FY ending Dec 2020 → FY ending Dec 2021

Revenue
+27.0%¥786.9B → ¥999.8B
Gross profit
+28.8%¥513.5B → ¥661.6B
Operating income
+40.1%¥301.2B → ¥421.9B
Net income attributable to owners
+41.1%¥214.7B → ¥303B
Operating cash flow
+36.4%¥205B → ¥279.6B
Free cash flow
+43.9%¥143.6B → ¥206.8B

Where the money goes

FY ending Dec 2020 → FY ending Dec 2021

Where ¥100 of sales goes

For every ¥100 Chugai sells, how much goes where, and how much is kept.

FY ending Dec 2021
Operating costs
¥58
Operating profit
¥42
Net profit kept
¥30

Annual margin trends

Gross margin66.2%
FY ending Dec 2019: 61.2%61.2%FY ending Dec 2020: 65.2%65.2%FY ending Dec 2021: 66.2%66.2%FY16FY17FY18FY19FY20FY21
Operating margin42.2%
FY ending Dec 2019: 30.7%30.7%FY ending Dec 2020: 38.3%38.3%FY ending Dec 2021: 42.2%42.2%FY16FY17FY18FY19FY20FY21
Net margin30.3%
FY ending Dec 2016: 10.9%10.9%FY ending Dec 2017: 13.6%13.6%FY ending Dec 2018: 16.0%16.0%FY ending Dec 2019: 23.0%23.0%FY ending Dec 2020: 27.3%27.3%FY ending Dec 2021: 30.3%30.3%FY16FY17FY18FY19FY20FY21

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第115期(2025/01/01-2025/12/31)

    ID S100XTBJ2026-03-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第114期(2024/01/01-2024/12/31)

    ID S100VHBT2025-03-27Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第113期(2023/01/01-2023/12/31)

    ID S100U3VS2024-07-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第112期(2022/01/01-2022/12/31)

    ID S100QH692023-03-30Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第111期(令和3年1月1日-令和3年12月31日)

    ID S100NSNY2022-03-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第110期(令和2年1月1日-令和2年12月31日)

    ID S100KZU52021-03-23Open

Extracted from XBRL: 37 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.